Source: Eur Respir Monogr 2020; 88: 167-183
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Etienne-Marie Jutant, Maria-Rosa Ghigna, David Montani, Marc Humbert. Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases. Eur Respir Monogr 2020; 88: 167-183

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension and cardiovascular diseases in ILD Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Pulmonary hypertension and cardiovascular diseases in ILD Source: ERS Course 2016 Year: 2016 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Cardiovascular comorbidities in chronic obstructive pulmonary disease patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation? Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018